Two Converging Technological Paradigms and Offer Bottom-Line Value To Any Organization

Microservices Journal

Subscribe to Microservices Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Microservices Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Microservices Authors: Liz McMillan, Madhavan Krishnan, VP, Cloud Solutions, Virtusa, Jason Bloomberg, Elizabeth White, Don MacVittie

News Feed Item

Cypress Bioscience, Inc. to Present at Oppenheimer's "Positioning Investors for the Next Wave in Pain Management" Conference

Cypress Bioscience, Inc. to Present at Oppenheimer's "Positioning Investors for the Next Wave in Pain Management" Conference

SAN DIEGO, CA -- (MARKET WIRE) -- 03/05/07 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at Oppenheimer's "Positioning Investors for the Next Wave in Pain Management" Conference on Tuesday, March 6, 2007.

The Oppenheimer conference is being held at the Flatotel Hotel, New York, NY. Ms. Johnson is scheduled to present on Tuesday, March 6th at 1:10 p.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at http://www.wsw.com/webcast/opp/cypb/.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience, Inc.

Cypress is committed to be the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's web site at www.cypressbio.com.

For additional information please contact
For Cypress Bioscience:
Sabrina Martucci Johnson
Executive VP, Chief Business Officer and Chief Financial Officer
Mary Gieson
Investor Relations
(858) 452-2323

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.